Perspective Therapeutics Share Price (NYSE: CATX)
Market is closed - opens 7 PM IST, 04 Aug 2025
$3.67
Last updated on 02 Aug 2025, 01:29 AM IST
Check the interactive Perspective Therapeutics Stock chart to analyse performance
Perspective Therapeutics stock performance
as on 02 Aug 2025, 01:29 AM IST
- Today's Low: $3.67Today's High: $3.82
0.0%
Downside
Day's Volatility :3.93%
Upside
3.93%
- 52 Weeks Low: $1.6052 Weeks High: $16.55
56.4%
Downside
52 Weeks Volatility :90.33%
Upside
77.82%
Perspective Therapeutics Stock Returns
Perspective Therapeutics Inc. Key Stats
Check Perspective Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Perspective Therapeutics Stock including INR - Dollar returns
The Perspective Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Perspective Therapeutics investment value today
Current value as on today
₹34,275
Returns
Returns from Perspective Therapeutics Stock
Dollar Returns*
₹4,413 (+4.41%)
Indian investors sentiment towards Perspective Therapeutics Stock
Analyst Recommendation on Perspective Therapeutics Stock
Buy
87%Buy
12%Hold
0%Sell
Based on 8 Wall street analysts offering stock ratings for Perspective Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Perspective Therapeutics Share Price Target
What analysts predicted
Upside of 284.39%
Target:
$14.11
Current:
$3.67
Perspective Therapeutics share price target is $14.11, a slight Upside of 284.39% compared to current price of $3.67 as per analysts' prediction.
Perspective Therapeutics Stock Insights
Price Movement
In the last 3 months, CATX stock has moved up by 43.6%Decreasing Revenue
Revenue is down for the last 2 quarters, 1.90M → 337.0K (in $), with an average decrease of 82.4% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, -40.16M → -18.17M (in $), with an average increase of 121.0% per quarterCATX vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 41.5% return, outperforming this stock by 111.6%Price to Sales
ForCATX every $1 of sales, investors are willing to pay $175.0, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.
Perspective Therapeutics Technicals Summary
Sell
Neutral
Buy
Perspective Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Perspective Therapeutics Inc. Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -0.14% | 11.36% | -70.1% | -3.29% | -3.29% |
 | 1.04% | -1.35% | 9.56% | -4.76% | -8.25% |
 | 3.27% | 11.1% | 30.36% | -23.34% | 1.64% |
 | 1.04% | 2.26% | 41.48% | 153.24% | 177.37% |
 | -4.34% | -3.33% | 14.04% | 75.14% | 97.35% |
 | -5.32% | -0.9% | 14.36% | 16.13% | 26.43% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -1.12 | -0.33 | -0.16 | NA | 3.84 |
| 25.39 | 25.39 | 2.15 | 5.46 | 0.1 | 0.04 | 0.03 | 37.46 |
| 33.19 | 33.19 | 4.76 | 2.49 | 0.17 | 0.08 | NA | 17.28 |
| 62.45 | 62.45 | 1.84 | 2.98 | 0.1 | 0.05 | NA | 15.02 |
| 53.22 | 53.22 | 2.34 | 13.4 | 0.14 | 0.07 | 0.01 | 54.77 |
| 15.81 | 15.81 | 4.17 | 5.14 | 0.31 | 0.06 | 0.02 | 28.06 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $301.4M | -3.29% | NA | 0.0% |
| Buy | $117.4B | -8.25% | 25.39 | 13.9% |
| Buy | $46.5B | 1.64% | 33.19 | 72.96% |
| Buy | $155.2B | 177.37% | 62.45 | 13.55% |
| Buy | $150.1B | 97.35% | 53.22 | 12.31% |
| Buy | $219.6B | 26.43% | 15.81 | 32.43% |
About Perspective Therapeutics Inc.
Key Management of Perspective Therapeutics Inc.
Important FAQs about investing in CATX Stock from India :
How to invest in Perspective Therapeutics Stock (CATX) from India?
It is very easy for Indian residents to invest directly in Perspective Therapeutics from India. Indian investors can
open a free US stocks account
on the INDmoney app. You can find live prices of the Perspective Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD).
Search for Perspective Therapeutics or CATX on the INDmoney app and click on Buy or SIP.
You can invest by choosing quantities of shares of Perspective Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Perspective Therapeutics
shares which would translate to 0.238 fractional shares
of Perspective Therapeutics as of today. Learn more about
fractional investing.
Can Indians buy Perspective Therapeutics shares?
Yes, Indians can invest in the Perspective Therapeutics (CATX) from India.
With INDmoney, you can buy Perspective Therapeutics at 0 brokerage. The step-by-step process is as follows:
- Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
- Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
- Once funds are transferred successfully, you can buy Perspective Therapeutics at zero transaction cost.
How can I buy Perspective Therapeutics shares from India?
It is very easy to buy Perspective Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Can Fractional shares of Perspective Therapeutics (CATX) be purchased?
Yes, you can buy fractional shares of Perspective Therapeutics with INDmoney app.
What are the documents required to start investing in Perspective Therapeutics stocks?
To start investing in Perspective Therapeutics, You will need the following documents:
- Proof of Identification (PAN, Aadhaar etc)
- Proof of address (Aadhaar, Voter ID etc)
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
What is Perspective Therapeutics share price today?
Perspective Therapeutics share price today stands at $3.67, Open: $3.82 ; Previous Close: $3.84 ; High: $3.82 ; Low: $3.67 ; 52 Week High: $16.55 ; 52 Week Low: $1.60.
The stock opens at $3.82, after a closing price of $3.84. The stock reached a daily high of $3.82 and a low of $3.67, with a 52-week high of $16.55 and a 52-week low of $1.60.
What are today’s High and Low prices of Perspective Therapeutics Stock (CATX)?
Today’s highest price of Perspective Therapeutics (CATX) is $3.82.
Today’s lowest price of Perspective Therapeutics (CATX) is $3.67.
What is the 52 Week High and Low Range of Perspective Therapeutics Stock (CATX)?
52 Week High
$16.55
52 Week Low
$1.60
What are the historical returns of Perspective Therapeutics (CATX)?
1 Month Returns
-0.14%
3 Months Returns
11.36%
1 Year Returns
-70.1%
5 Years Returns
-3.29%
What is today's market capitalisation of Perspective Therapeutics?
Who is the Chief Executive Officer (CEO) of Perspective Therapeutics ?
Discover More
Direxion Daily Gold Miners Index Bull 2x Etf$74.50
+3.04%
Freedom Acquisition I Corp-a$10.28
-0.1%
Blackrock Future Health Etf$24.66
-0.2%
Esgl Holdings Ltd$2.80
-4.76%
- Invesco S&p Midcap 400 Garp Etf
$112.72
-1.21%
- Scienture Holdings Inc
$1.93
-0.52%
- Future Vision Ii Acquisition Corp.
$10.49
-0.29%
- Timothy Plan Us Large/mid Cap Core Etf
$44.80
-1.13%